AstraZeneca's Enhertu gets new US approval, Segro JV buys six logistics assets
Stocks to watch AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the US for the treatment of adults with HER2 breast cancer, after disease progression having had one or more hormone therapies. The approval was granted by the Food and Drug …